Ebola Can No Longer be Called an Incurable Disease

1319
- Advertisement -

Update on Ebola drug trial: two strong performers identified

WHO/Christopher Black
WHO/Christopher Black

Mega Doctor News

The co-sponsors of the Ebola therapeutics trial in the Democratic Republic of the Congo (DRC) have announced advances that will bring patients a better chance of survival. Two out of the four drugs being tested are more effective in treating Ebola. Moving forward, these are the only drugs that future patients will be treated with.

This World Health Organization (WHO) initiative is the first-ever multi-drug randomized control trial aimed at evaluating the safety and efficacy of four drugs used for the treatment of Ebola patients.

In addition to researching the best treatments for Ebola, other efforts by team members and partners in the field are also critical in impacting survival rates.  Teams of epidemiologists and community members work with communities to identify cases and provide care as quickly as possible. The teams ensure contacts are vaccinated against the disease and that their health is monitored for three weeks. Active case finding, contact tracing, and community acceptance of these teams are vital to ending the outbreak.

The WHO is committed to continuing to work closely with the ministries of health of DRC and neighboring countries, and other international partners to ensure the outbreak response remains robust and well-coordinated.  We will continue to conduct rigorous research and incorporate findings into the Ebola outbreak response through a variety of prevention and control strategies. 

Source: World Health Organization

- Advertisement -